共 50 条
- [11] Advancements in Biologic Therapy for Psoriasis: the IL-23 Inhibitors [J]. Current Dermatology Reports, 2021, 10 : 6 - 15
- [12] Tildrakizumab (Ilumya) - Another IL-23 Antagonist for Psoriasis [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1563): : 4 - 6
- [14] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis [J]. LANCET, 2021, 397 (10275): : 754 - 766
- [17] Importance of IL-23 and Th17 Cells in Psoriasis [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 66 - 67
- [19] Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis [J]. JOURNAL OF IMMUNOLOGY, 2018, 201 (06): : 1605 - 1613